BOUNDLESS BIO, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-46.9M | $-47.5M | $633.0K | $3.3M |
| FY2024 | $-60.8M | $-63.4M | $2.5M | $7.5M |
| FY2025 | $-46.7M | $-47.2M | $546.0K | $6.1M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-46.9M | $-47.5M | $633.0K | $3.3M |
| FY2024 | $-60.8M | $-63.4M | $2.5M | $7.5M |
| FY2025 | $-46.7M | $-47.2M | $546.0K | $6.1M |